Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Roupret

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Annals of Surgical Oncology|October 31, 2013
Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French studyGéraldine Pignot, Laurent Salomon, Yann Neuzillet, et al.
European Urology|April 11, 2009
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgeryKarim Bensalah, Allan J Pantuck, Nathalie Rioux-Leclercq, et al.
World Journal of Urology|November 7, 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 casesPaolo Gontero, Francesca Pisano, Joan Palou, et al.
World Journal of Urology|October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year studyMario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
BJU International|October 6, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomyFrancesco Pellegrino, Mario de Angelis, Pietro Scilipoti, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
Nature Reviews. Urology|April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensusRoberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Carcinogenesis|March 26, 2014
Genome-wide interaction study of smoking and bladder cancer riskJonine D Figueroa, Summer S Han, Montserrat Garcia-Closas, et al.
Human Molecular Genetics|October 29, 2013
Genome-wide association study identifies multiple loci associated with bladder cancer riskJonine D Figueroa, Yuanqing Ye, Afshan Siddiq, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Annals of Surgical Oncology|October 31, 2013
Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French studyGéraldine Pignot, Laurent Salomon, Yann Neuzillet, et al.
European Urology|April 11, 2009
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgeryKarim Bensalah, Allan J Pantuck, Nathalie Rioux-Leclercq, et al.
World Journal of Urology|November 7, 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 casesPaolo Gontero, Francesca Pisano, Joan Palou, et al.
World Journal of Urology|October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year studyMario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
BJU International|October 6, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomyFrancesco Pellegrino, Mario de Angelis, Pietro Scilipoti, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
Nature Reviews. Urology|April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensusRoberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
Cancer Discovery|August 5, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder CancerAnne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, et al.
Carcinogenesis|March 26, 2014
Genome-wide interaction study of smoking and bladder cancer riskJonine D Figueroa, Summer S Han, Montserrat Garcia-Closas, et al.
Human Molecular Genetics|October 29, 2013
Genome-wide association study identifies multiple loci associated with bladder cancer riskJonine D Figueroa, Yuanqing Ye, Afshan Siddiq, et al.
Pageof 28